Evidence map›Paper›PMID 27485057›Full record

SynthesisHPB : the official journal of the International Hepato Pancreato Biliary Association2016

Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features.

Christos Agalianos, Nikolaos Gouvas, Kleo Papaparaskeva, Christos Dervenis

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Systemic Therapy for Metastatic Pancreatic Cancer.Current treatment options in oncology · 2021
    Review
  12. Article
  13. Article
  14. Role of lymphadenectomy in resectable pancreatic cancer.Langenbeck's archives of surgery · 2020
    Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christos AgalianosAthens Naval and Veterans Hospital, Department of Surgery, Athens, Greece. Electronic address: xagali@gmail.com.
Nikolaos Gouvas"Konstantopouleio" Hospital of Athens, Department of Surgery, Athens, Greece.
Kleo Papaparaskeva"Konstantopouleio" Hospital of Athens, Department of Pathology, Athens, Greece.
Christos Dervenis"Konstantopouleio" Hospital of Athens, Department of Surgery, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relation between para-aortic lymph nodes (PALN) involvement and pancreatic ductal adenocarcinoma (PDAC) survival, along with the optimal handling of this particular lymph node station remain unclear. A systematic review and meta-analysis was performed to assess this.

methodsA search of Medline, Embase, Ovid and Cochrane databases was performed until July 2015 to identify studies reporting on the relation of PALN involvement and PDAC outcomes and a meta-analysis was performed following data extraction.

resultsTen retrospective studies and two prospective non randomized studies (2467 patients) were included. Patients with positive PALN had worse one (p < 0.00001) and two year (p < 0.00001) survival when compared with patients with negative PALN. Even when comparing only patients with positive lymph nodes (N1), patients with PALN involvement presented with a significant lower one (p = 0.03) and two (p = 0.002) year survival. PALN involvement was associated with an increased possibility of positive margin (R1) resection (p < 0.00001), stations' 12, 14 and 17 malignant infiltration (p < 0.00001), but not with tumour stage (p = 0.78). DISCUSSION: Involvement of PALN is associated with decreased survival in pancreatic cancer patients. However, existence of long term survivors among this subgroup of patients should be further evaluated, in order to identify factors associated with their favourable prognosis.

Indexed as

PancreatectomyCarcinoma, Pancreatic DuctalChi-Square DistributionFemaleHumansLymphatic MetastasisLymph NodesMaleMargins of ExcisionMiddle AgedNeoplasm, ResidualNeoplasm StagingOdds RatioPancreatic NeoplasmsRisk AssessmentRisk Factors

Identifiers

PMID27485057
PMCPMC4972380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.